IceCure Medical is a medical device company based in Israel, developing minimally-invasive treatment for tumors. IceCure’s core technology is based on cryoablation, using freezing temperature (liquid nitrogen) to destroy tumors safely, quickly, and painlessly without the need for surgery.

IceCure’s next generation cryoablation technology, the ProSense system, enables rapid minimally-invasive, safe, and effective treatment of breast lesions in-office or ambulatory hospital settings.